Septodont.

Septodont's January 2025 release with Premier Dental says the group was founded in 1932 by Annie and Nestor Schiller and is headquartered in Saint-Maur-des-Fosses, France, with a U.S. headquarters in Lancaster, Pennsylvania. A 2022 note from Olivier Schiller, CEO, describes the founders as his grandparents and his father as the person who expanded the company internationally. The 2025 CSR report calls Septodont a French family-owned group with seven production sites and says it supplies professionals in more than 110 countries. An older about page cites different employee and country counts. This profile uses the 2025 CSR figures and does not average them.

The CSR map names plants in Saint-Maur and Mazamet in France, Cambridge in Canada for Novocol injectables, Taloja in India, Barcelona for Inibsa, and Catanduva and Pomerode in Brazil. The timeline records acquisitions that built that map: Novocol in Canada, Ultracaine products from Sanofi, Sofic needles in France, a majority stake in Inibsa in Spain, and biomedical-tissue and Brazilian accessory businesses. Pain management and dental therapeutics are the two columns the report uses.

On the U.S. homepage the products in front are BufferPro, Biodentine XP, BioRoot Flow, and Septocaine. Articaine cartridges, a dentin substitute, and a bioceramic sealer do not share a setup. The assistant who sets out a syringe is not the assistant who mixes Biodentine unless the procedure is the same visit by plan.

Marketing lines on the about page include very large patient and injection counts. They are the company's scale claims. They are not needed to choose a cartridge. The practical facts are the drug, the concentration, the vasoconstrictor ratio, and the expiration date on the blister.

Septodont suits every practice that injects local anesthetic and wants a branded articaine or a related cartridge, plus offices that use Biodentine for pulp-adjacent restoration and BioRoot for obturation. Oral surgery and endodontics are in that second group. The bases and liners guide is the closest how-to-choose page for a dentin substitute. The bone-grafting guide is the context for a synthetic membrane such as R.T.R., not for Septocaine.

BufferPro is a joint launch with Premier Dental. It is a buffering step before injection. Practices that do not buffer can ignore it. Practices that do should follow the mixture instructions rather than a blog summary.

A laboratory is not the anesthetic buyer. A lab might see BioRoot only if the dentist sealed the canal before a post. The material choice stays with the clinician.

Other companies sell lidocaine and articaine. Compare the vasoconstrictor ratio and the approved indication, not the carton color. Septodont's timeline presents Septocaine as the first U.S. articaine. That is a history sentence. It does not mean another articaine is inappropriate.

Biodentine is not a composite. Pulpdent paste is a calcium hydroxide dressing. Biodentine is described by Septodont as a dentin substitute. Read both inserts before you treat them as backups for each other. BioRoot is a sealer. It is not an endodontic file.

Oraverse is a reversal agent. It is not an anesthetic and not a sedative. Stock it only if the practice has a protocol for when to reverse.

Anesthetic is a drug. Track lot, expiry, and the epinephrine concentration your doctors actually use. A 1:100,000 cartridge is the one named on the U.S. homepage for Septocaine. Confirm other ratios before you assume they are on the same order form.

Read the cartridge before it goes in the syringe. The label carries the drug name, the concentration, the vasoconstrictor ratio, the lot, and the expiration date. A blister that looks like the one next to it can still be a different ratio or a different drug. The package insert that ships with that box is the instruction. This profile is not a substitute for it, and it does not list a dose.

Manufacturing site can vary. The CSR lists seven plants. A needle from Mazamet and a cartridge from Saint-Maur or Cambridge are different supply chains. Your dealer invoice may not name the plant. The box will. Keep the IFU that matches the box.

U.S. headquarters in the 2025 release is Lancaster, Pennsylvania. Warranty is the wrong word for a drug. Ask about return of unopened, unexpired cartridges and about adverse-event reporting. Education is mentioned in the CSR as something the group invests in. It is not a condition of buying a blister unless your rep says so.